Loading…
Reported covered position: Intern, Sen. Mark Warner
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Patients Deserve Price Tags Act (S. 2355/H.R. 5582); issues related to federal employee healthcare; legislation related to tax-advantaged health savings vehicles; healthcare financial services policies; healthcare waste, fraud, and abuse; legislative concepts related to direct contracting in employer-sponsored healthcare; anti-competitive practices and anti-tiering/anti-steering legislation.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
NOMI HEALTH, INC. via NOMI HEALTH, INC.
2026 · third_quarter · Q3
ERISA healthcare issues; employer data ownership and transparency legislation; regulations on service provider fee disclosure.
Patients Deserve Price Tags Act (S. 2355/H.R. 5582); Health Data Access, Transparency, and Affordability Act of 2026 (H.R. 9228/H.R. 9486); issues related to federal employee healthcare; legislation related to tax-advantaged health savings vehicles; healthcare financial services policies; healthcare waste, fraud, and abuse; legislative concepts related to direct contracting in employer-sponsored healthcare; anti-competitive practices and anti-tiering/anti-steering legislation.
Source: Senate LDA
Patients Deserve Price Tags Act (S. 2355/H.R. 5582); Health Data Access, Transparency, and Affordability Act of 2026 (H.R. 9228/H.R. 9486); issues related to federal employee healthcare; legislation related to tax-advantaged health savings vehicles; healthcare financial services policies; healthcare waste, fraud, and abuse; legislative concepts related to direct contracting in employer-sponsored healthcare; anti-competitive practices and anti-tiering/anti-steering legislation.
Patients Deserve Price Tags Act (S. 2355/H.R. 5582); Health Data Access, Transparency, and Affordability Act of 2026 (H.R. 9228); issues related to federal employee healthcare; legislation related to tax-advantaged health savings vehicles; healthcare financial services policies; healthcare waste, fraud, and abuse; legislative concepts related to direct contracting in employer-sponsored healthcare; anti-competitive practices and anti-tiering/anti-steering legislation.
Patients Deserve Price Tags Act (S. 2355/H.R. 5582); Health Data Access, Transparency, and Affordability Act of 2026 (H.R. 9228); issues related to federal employee healthcare; legislation related to tax-advantaged health savings vehicles; healthcare financial services policies; healthcare waste, fraud, and abuse; legislative concepts related to direct contracting in employer-sponsored healthcare; anti-competitive practices and anti-tiering/anti-steering legislation.
Patients Deserve Price Tags Act (S. 2355/H.R. 5582); Health Data Access, Transparency, and Affordability Act of 2026 (H.R. 9228/H.R. 9486); issues related to federal employee healthcare; legislation related to tax-advantaged health savings vehicles; healthcare financial services policies; healthcare waste, fraud, and abuse; legislative concepts related to direct contracting in employer-sponsored healthcare; anti-competitive practices and anti-tiering/anti-steering legislation.
Patients Deserve Price Tags Act (S. 2355/H.R. 5582); Health Data Access, Transparency, and Affordability Act of 2026 (H.R. 9228/H.R. 9486); issues related to federal employee healthcare; legislation related to tax-advantaged health savings vehicles; healthcare financial services policies; healthcare waste, fraud, and abuse; legislative concepts related to direct contracting in employer-sponsored healthcare; anti-competitive practices and anti-tiering/anti-steering legislation.
Patients Deserve Price Tags Act (S. 2355/H.R. 5582); Health Data Access, Transparency, and Affordability Act of 2026 (H.R. 9228/H.R. 9486); issues related to federal employee healthcare; legislation related to tax-advantaged health savings vehicles; healthcare financial services policies; healthcare waste, fraud, and abuse; legislative concepts related to direct contracting in employer-sponsored healthcare; anti-competitive practices and anti-tiering/anti-steering legislation.
Patients Deserve Price Tags Act (S. 2355/H.R. 5582); issues related to federal employee healthcare; legislation related to tax-advantaged health savings vehicles; healthcare financial services policies; healthcare waste, fraud, and abuse; legislative concepts related to direct contracting in employer-sponsored healthcare; anti-competitive practices and anti-tiering/anti-steering legislation.
Patients Deserve Price Tags Act (S. 2355/H.R. 5582); Health Data Access, Transparency, and Affordability Act of 2026 (H.R. 9228); issues related to federal employee healthcare; legislation related to tax-advantaged health savings vehicles; healthcare financial services policies; healthcare waste, fraud, and abuse; legislative concepts related to direct contracting in employer-sponsored healthcare; anti-competitive practices and anti-tiering/anti-steering legislation.
Patients Deserve Price Tags Act (S. 2355/H.R. 5582), legislation related to tax-advantaged health savings vehicles; healthcare financial services policies; healthcare waste, fraud, and abuse; legislative concepts related to direct contracting in employer-sponsored healthcare; anti-competitive practices and anti-tiering/anti-steering legislation.
Patients Deserve Price Tags Act (S. 2355), legislation related to tax-advantaged health savings vehicles; healthcare financial services policies; healthcare waste, fraud, and abuse; legislative concepts related to direct contracting in employer-sponsored healthcare; anti-competitive practices and anti-tiering/anti-steering legislation.
Patients Deserve Price Tags Act (S. 2355/H.R. 5582), legislation related to tax-advantaged health savings vehicles; healthcare financial services policies; healthcare waste, fraud, and abuse; legislative concepts related to direct contracting in employer-sponsored healthcare; anti-competitive practices and anti-tiering/anti-steering legislation.
Reentry Act of 2023 (H.R. 2400/S. 1165); Support for Patients and Communities Reauthorization Act (H.R. 4531/S. 3393); Due Process Continuity of Care Act (H.R. 3074/S. 971); GOLD CARD Act of 2023 (H.R. 4968); Pharmacy benefit manager policies and legislation; Medication-assisted treatment expansion; healthcare financial services policies; healthcare cybersecurity policies
Reentry Act of 2023 (H.R. 2400/S. 1165); Support for Patients and Communities Reauthorization Act (H.R. 4531/S. 3393); Due Process Continuity of Care Act (H.R. 3074/S. 971); GOLD CARD Act of 2023 (H.R. 4968); Pharmacy benefit manager policies and legislation; Medication-assisted treatment expansion; healthcare financial services policies; healthcare cybersecurity policies
Reentry Act of 2023 (H.R. 2400/S. 1165); Support for Patients and Communities Reauthorization Act (H.R. 4531/S. 3393); Due Process Continuity of Care Act (H.R. 3074/S. 971); GOLD CARD Act of 2023 (H.R. 4968); Pharmacy benefit manager policies and legislation; Medication-assisted treatment expansion; healthcare financial services policies; healthcare cybersecurity policies
Reentry Act of 2023 (H.R. 2400/S. 1165); Support for Patients and Communities Reauthorization Act (H.R. 4531/S. 3393); Due Process Continuity of Care Act (H.R. 3074/S. 971); GOLD CARD Act of 2023 (H.R. 4968); Pharmacy benefit manager policies and legislation; Medication-assisted treatment expansion; healthcare financial services policies; healthcare cybersecurity policies
Support for Patients and Communities Reauthorization Act
Client: NOMI HEALTH, INC. · Firm: NOMI HEALTH, INC.
Reentry Act of 2023 (H.R. 2400/S. 1165); Support for Patients and Communities Reauthorization Act (H.R. 4531/S. 3393); Due Process Continuity of Care Act (H.R. 3074/S. 971); GOLD CARD Act of 2023 (H.R. 4968); Pharmacy benefit manager policies and legislation; Medication-assisted treatment expansion; healthcare financial services policies; healthcare cybersecurity policies
Support for Patients and Communities Reauthorization Act
Client: NOMI HEALTH, INC. · Firm: NOMI HEALTH, INC.
Reentry Act of 2023 (H.R. 2400/S. 1165); Support for Patients and Communities Reauthorization Act (H.R. 4531/S. 3393); Due Process Continuity of Care Act (H.R. 3074/S. 971); GOLD CARD Act of 2023 (H.R. 4968); Pharmacy benefit manager policies and legislation; Medication-assisted treatment expansion; healthcare financial services policies; healthcare cybersecurity policies
Reentry Act of 2023 (H.R. 2400/S. 1165); Support for Patients and Communities Reauthorization Act (H.R. 4531/S. 3393); Due Process Continuity of Care Act (H.R. 3074/S. 971); GOLD CARD Act of 2023 (H.R. 4968); Pharmacy benefit manager policies and legislation; Medication-assisted treatment expansion; healthcare financial services policies; healthcare cybersecurity policies
Reentry Act of 2023 (H.R. 2400/S. 1165); Support for Patients and Communities Reauthorization Act (H.R. 4531/S. 3393); Due Process Continuity of Care Act (H.R. 3074/S. 971); GOLD CARD Act of 2023 (H.R. 4968); Pharmacy benefit manager policies and legislation; Medication-assisted treatment expansion; healthcare financial services policies; healthcare cybersecurity policies
GOLD CARD Act of 2023 (H.R. 4968); pharmacy benefit manager policies and legislation; medication-assisted treatment expansion; telehealth controlled substances legislation; healthcare financial services policies; healthcare cybersecurity policies; S. 5218 (related to healthcare cybersecurity); Healthcare Cybersecurity Act of 2024 (S. 4697/H.R. 9412).
pharmacy benefit manager policies and legislation; medication-assisted treatment expansion; HOPE Act (H.R. 9394); telehealth controlled substances legislation; healthcare financial services policies; healthcare cybersecurity policies; S. 5218 (related to healthcare cybersecurity); Healthcare Cybersecurity Act of 2024 (S. 4697/H.R. 9412).
pharmacy benefit manager policies and legislation; medication-assisted treatment expansion; HOPE Act (H.R. 9394); telehealth controlled substances legislation; healthcare financial services policies; healthcare cybersecurity policies; S. 5218 (related to healthcare cybersecurity); Healthcare Cybersecurity Act of 2024 (S. 4697/H.R. 9412).
GOLD CARD Act of 2023 (H.R. 4968); pharmacy benefit manager policies and legislation; medication-assisted treatment expansion; telehealth controlled substances legislation; healthcare financial services policies; healthcare cybersecurity policies; S. 5218 (related to healthcare cybersecurity); Healthcare Cybersecurity Act of 2024 (S. 4697/H.R. 9412).
Reentry Act of 2023 (H.R. 2400/S. 1165); Support for Patients and Communities Reauthorization Act (H.R. 4531/S. 3393); Due Process Continuity of Care Act (H.R. 3074/S. 971); GOLD CARD Act of 2023 (H.R. 4968); Pharmacy benefit manager policies and legislation; Medication-assisted treatment expansion; healthcare financial services policies; healthcare cybersecurity policies
Reentry Act of 2023 (H.R. 2400/S. 1165); Support for Patients and Communities Reauthorization Act (H.R. 4531/S. 3393); Due Process Continuity of Care Act (H.R. 3074/S. 971); GOLD CARD Act of 2023 (H.R. 4968); Pharmacy benefit manager policies and legislation; Medication-assisted treatment expansion; healthcare financial services policies; healthcare cybersecurity policies
SUPPORT for Patients and Communities Reauthorization Act
Client: NOMI HEALTH, INC. · Firm: NOMI HEALTH, INC.
Reentry Act of 2023 (H.R. 2400/S. 1165); Support for Patients and Communities Reauthorization Act (H.R. 4531/S. 3393); Due Process Continuity of Care Act (H.R. 3074/S. 971); GOLD CARD Act of 2023 (H.R. 4968); Pharmacy benefit manager policies and legislation; Medication-assisted treatment expansion; healthcare financial services policies; healthcare cybersecurity policies
SUPPORT for Patients and Communities Reauthorization Act
Client: NOMI HEALTH, INC. · Firm: NOMI HEALTH, INC.
Reentry Act of 2023 (H.R. 2400/S. 1165); Support for Patients and Communities Reauthorization Act (H.R. 4531/S. 3393); Due Process Continuity of Care Act (H.R. 3074/S. 971); GOLD CARD Act of 2023 (H.R. 4968); Pharmacy benefit manager policies and legislation; Medication-assisted treatment expansion; healthcare financial services policies; healthcare cybersecurity policies
GOLD CARD Act of 2023 (H.R. 4968); pharmacy benefit manager policies and legislation; medication-assisted treatment expansion; telehealth controlled substances legislation; healthcare financial services policies; healthcare cybersecurity policies; S. 5218 (related to healthcare cybersecurity); Healthcare Cybersecurity Act of 2024 (S. 4697/H.R. 9412).
pharmacy benefit manager policies and legislation; medication-assisted treatment expansion; HOPE Act (H.R. 9394); telehealth controlled substances legislation; healthcare financial services policies; healthcare cybersecurity policies; S. 5218 (related to healthcare cybersecurity); Healthcare Cybersecurity Act of 2024 (S. 4697/H.R. 9412).
Health Infrastructure Security and Accountability Act of 2024
Client: NOMI HEALTH, INC. · Firm: NOMI HEALTH, INC.
GOLD CARD Act of 2023 (H.R. 4968); pharmacy benefit manager policies and legislation; medication-assisted treatment expansion; telehealth controlled substances legislation; healthcare financial services policies; healthcare cybersecurity policies; S. 5218 (related to healthcare cybersecurity); Healthcare Cybersecurity Act of 2024 (S. 4697/H.R. 9412).
Health Infrastructure Security and Accountability Act of 2024
Client: NOMI HEALTH, INC. · Firm: NOMI HEALTH, INC.
pharmacy benefit manager policies and legislation; medication-assisted treatment expansion; HOPE Act (H.R. 9394); telehealth controlled substances legislation; healthcare financial services policies; healthcare cybersecurity policies; S. 5218 (related to healthcare cybersecurity); Healthcare Cybersecurity Act of 2024 (S. 4697/H.R. 9412).
Reentry Act of 2023 (H.R. 2400/S. 1165); Support for Patients and Communities Reauthorization Act (H.R. 4531/S. 3393); Due Process Continuity of Care Act (H.R. 3074/S. 971); GOLD CARD Act of 2023 (H.R. 4968); Pharmacy benefit manager policies and legislation; Medication-assisted treatment expansion; healthcare financial services policies; healthcare cybersecurity policies
Reentry Act of 2023 (H.R. 2400/S. 1165); Support for Patients and Communities Reauthorization Act (H.R. 4531/S. 3393); Due Process Continuity of Care Act (H.R. 3074/S. 971); GOLD CARD Act of 2023 (H.R. 4968); Pharmacy benefit manager policies and legislation; Medication-assisted treatment expansion; healthcare financial services policies; healthcare cybersecurity policies
Reentry Act of 2023 (H.R. 2400/S. 1165); Support for Patients and Communities Reauthorization Act (H.R. 4531/S. 3393); Due Process Continuity of Care Act (H.R. 3074/S. 971); GOLD CARD Act of 2023 (H.R. 4968); Pharmacy benefit manager policies and legislation; Medication-assisted treatment expansion
Reentry Act of 2023 (H.R. 2400/S. 1165) Support for Patients and Communities Reauthorization Act (H.R. 4531/S. 3393) Due Process Continuity of Care Act (H.R. 3074/S. 971) Fiscal Year (FY 2024) Labor-HHS-Education Appropriations (H.R. 5894/S. 2624) COVID funding and related issues Pharmacy benefit manager policies and legislation Medication-assisted treatment expansion
Reentry Act of 2023 (H.R. 2400/S. 1165) Support for Patients and Communities Reauthorization Act (H.R. 4531/S. 3393) Due Process Continuity of Care Act (H.R. 3074/S. 971) Fiscal Year (FY 2024) Labor-HHS-Education Appropriations (H.R. 5894/S. 2624) COVID funding and related issues Pharmacy benefit manager policies and legislation Medication-assisted treatment expansion
Reentry Act of 2023 (H.R. 2400/S. 1165) Support for Patients and Communities Reauthorization Act (H.R. 4531/S. 3393) Due Process Continuity of Care Act (H.R. 3074/S. 971) Fiscal Year (FY 2024) Labor-HHS-Education Appropriations (H.R. 5894/S. 2624) COVID funding and related issues Pharmacy benefit manager policies and legislation Medication-assisted treatment expansion
Reentry Act of 2023 (H.R. 2400/S. 1165); Support for Patients and Communities Reauthorization Act (H.R. 4531/S. 3393); Due Process Continuity of Care Act (H.R. 3074/S. 971); GOLD CARD Act of 2023 (H.R. 4968); Pharmacy benefit manager policies and legislation; Medication-assisted treatment expansion
Reentry Act of 2023 (H.R. 2400/S. 1165) Support for Patients and Communities Reauthorization Act (H.R. 4531/S. 3393) Due Process Continuity of Care Act (H.R. 3074/S. 971) Fiscal Year (FY 2024) Labor-HHS-Education Appropriations (H.R. 5894/S. 2624) COVID funding and related issues Pharmacy benefit manager policies and legislation Medication-assisted treatment expansion
Support for Patients and Communities Reauthorization Act
Client: NOMI HEALTH, INC. · Firm: NOMI HEALTH, INC.
Reentry Act of 2023 (H.R. 2400/S. 1165); Support for Patients and Communities Reauthorization Act (H.R. 4531/S. 3393); Due Process Continuity of Care Act (H.R. 3074/S. 971); GOLD CARD Act of 2023 (H.R. 4968); Pharmacy benefit manager policies and legislation; Medication-assisted treatment expansion
Support for Patients and Communities Reauthorization Act
Client: NOMI HEALTH, INC. · Firm: NOMI HEALTH, INC.
Reentry Act of 2023 (H.R. 2400/S. 1165) Support for Patients and Communities Reauthorization Act (H.R. 4531/S. 3393) Due Process Continuity of Care Act (H.R. 3074/S. 971) Fiscal Year (FY 2024) Labor-HHS-Education Appropriations (H.R. 5894/S. 2624) COVID funding and related issues Pharmacy benefit manager policies and legislation Medication-assisted treatment expansion
Support for Patients and Communities Reauthorization Act
Client: NOMI HEALTH, INC. · Firm: NOMI HEALTH, INC.
Reentry Act of 2023 (H.R. 2400/S. 1165) Support for Patients and Communities Reauthorization Act (H.R. 4531/S. 3393) Due Process Continuity of Care Act (H.R. 3074/S. 971) Fiscal Year (FY 2024) Labor-HHS-Education Appropriations (H.R. 5894/S. 2624) COVID funding and related issues Pharmacy benefit manager policies and legislation Medication-assisted treatment expansion
Reentry Act of 2023 (H.R. 2400/S. 1165); Support for Patients and Communities Reauthorization Act (H.R. 4531/S. 3393); Due Process Continuity of Care Act (H.R. 3074/S. 971); GOLD CARD Act of 2023 (H.R. 4968); Pharmacy benefit manager policies and legislation; Medication-assisted treatment expansion
Making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2024, and for other purposes.
Client: NOMI HEALTH, INC. · Firm: NOMI HEALTH, INC.
Reentry Act of 2023 (H.R. 2400/S. 1165) Support for Patients and Communities Reauthorization Act (H.R. 4531/S. 3393) Due Process Continuity of Care Act (H.R. 3074/S. 971) Fiscal Year (FY 2024) Labor-HHS-Education Appropriations (H.R. 5894/S. 2624) COVID funding and related issues Pharmacy benefit manager policies and legislation Medication-assisted treatment expansion
Making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2024, and for other purposes.
Client: NOMI HEALTH, INC. · Firm: NOMI HEALTH, INC.
Reentry Act of 2023 (H.R. 2400/S. 1165) Support for Patients and Communities Reauthorization Act (H.R. 4531/S. 3393) Due Process Continuity of Care Act (H.R. 3074/S. 971) Fiscal Year (FY 2024) Labor-HHS-Education Appropriations (H.R. 5894/S. 2624) COVID funding and related issues Pharmacy benefit manager policies and legislation Medication-assisted treatment expansion
Making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2024, and for other purposes.
Client: NOMI HEALTH, INC. · Firm: NOMI HEALTH, INC.
Fiscal Year (FY 2024) Labor-HHS-Education Appropriations (H.R. 5894/S. 2624); COVID funding and related issues
Reentry Act of 2023 (H.R. 2400/S. 1165) Support for Patients and Communities Reauthorization Act (H.R. 4531/S. 3393) Due Process Continuity of Care Act (H.R. 3074/S. 971) Fiscal Year (FY 2024) Labor-HHS-Education Appropriations (H.R. 5894/S. 2624) COVID funding and related issues Pharmacy benefit manager policies and legislation Medication-assisted treatment expansion
Reentry Act of 2023 (H.R. 2400/S. 1165); Support for Patients and Communities Reauthorization Act (H.R. 4531/S. 3393); Due Process Continuity of Care Act (H.R. 3074/S. 971); GOLD CARD Act of 2023 (H.R. 4968); Pharmacy benefit manager policies and legislation; Medication-assisted treatment expansion
Reentry Act of 2023 (H.R. 2400/S. 1165) Support for Patients and Communities Reauthorization Act (H.R. 4531/S. 3393) Due Process Continuity of Care Act (H.R. 3074/S. 971) Fiscal Year (FY 2024) Labor-HHS-Education Appropriations (H.R. 5894/S. 2624) COVID funding and related issues Pharmacy benefit manager policies and legislation Medication-assisted treatment expansion
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2024
Client: NOMI HEALTH, INC. · Firm: NOMI HEALTH, INC.
Fiscal Year (FY 2024) Labor-HHS-Education Appropriations (H.R. 5894/S. 2624); COVID funding and related issues
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2024
Client: NOMI HEALTH, INC. · Firm: NOMI HEALTH, INC.
Reentry Act of 2023 (H.R. 2400/S. 1165) Support for Patients and Communities Reauthorization Act (H.R. 4531/S. 3393) Due Process Continuity of Care Act (H.R. 3074/S. 971) Fiscal Year (FY 2024) Labor-HHS-Education Appropriations (H.R. 5894/S. 2624) COVID funding and related issues Pharmacy benefit manager policies and legislation Medication-assisted treatment expansion
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2024
Client: NOMI HEALTH, INC. · Firm: NOMI HEALTH, INC.
Reentry Act of 2023 (H.R. 2400/S. 1165) Support for Patients and Communities Reauthorization Act (H.R. 4531/S. 3393) Due Process Continuity of Care Act (H.R. 3074/S. 971) Fiscal Year (FY 2024) Labor-HHS-Education Appropriations (H.R. 5894/S. 2624) COVID funding and related issues Pharmacy benefit manager policies and legislation Medication-assisted treatment expansion
SUPPORT for Patients and Communities Reauthorization Act
Client: NOMI HEALTH, INC. · Firm: NOMI HEALTH, INC.
Reentry Act of 2023 (H.R. 2400/S. 1165); Support for Patients and Communities Reauthorization Act (H.R. 4531/S. 3393); Due Process Continuity of Care Act (H.R. 3074/S. 971); GOLD CARD Act of 2023 (H.R. 4968); Pharmacy benefit manager policies and legislation; Medication-assisted treatment expansion
SUPPORT for Patients and Communities Reauthorization Act
Client: NOMI HEALTH, INC. · Firm: NOMI HEALTH, INC.
Reentry Act of 2023 (H.R. 2400/S. 1165) Support for Patients and Communities Reauthorization Act (H.R. 4531/S. 3393) Due Process Continuity of Care Act (H.R. 3074/S. 971) Fiscal Year (FY 2024) Labor-HHS-Education Appropriations (H.R. 5894/S. 2624) COVID funding and related issues Pharmacy benefit manager policies and legislation Medication-assisted treatment expansion
SUPPORT for Patients and Communities Reauthorization Act
Client: NOMI HEALTH, INC. · Firm: NOMI HEALTH, INC.
Reentry Act of 2023 (H.R. 2400/S. 1165) Support for Patients and Communities Reauthorization Act (H.R. 4531/S. 3393) Due Process Continuity of Care Act (H.R. 3074/S. 971) Fiscal Year (FY 2024) Labor-HHS-Education Appropriations (H.R. 5894/S. 2624) COVID funding and related issues Pharmacy benefit manager policies and legislation Medication-assisted treatment expansion
Reentry Act of 2023 (H.R. 2400/S. 1165); Support for Patients and Communities Reauthorization Act (H.R. 4531/S. 3393); Due Process Continuity of Care Act (H.R. 3074/S. 971); GOLD CARD Act of 2023 (H.R. 4968); Pharmacy benefit manager policies and legislation; Medication-assisted treatment expansion
Reentry Act of 2023 (H.R. 2400/S. 1165) Support for Patients and Communities Reauthorization Act (H.R. 4531/S. 3393) Due Process Continuity of Care Act (H.R. 3074/S. 971) Fiscal Year (FY 2024) Labor-HHS-Education Appropriations (H.R. 5894/S. 2624) COVID funding and related issues Pharmacy benefit manager policies and legislation Medication-assisted treatment expansion
Reentry Act of 2023 (H.R. 2400/S. 1165) Support for Patients and Communities Reauthorization Act (H.R. 4531/S. 3393) Due Process Continuity of Care Act (H.R. 3074/S. 971) Fiscal Year (FY 2024) Labor-HHS-Education Appropriations (H.R. 5894/S. 2624) COVID funding and related issues Pharmacy benefit manager policies and legislation Medication-assisted treatment expansion
Filing targets: HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL), SENATE
NOMI HEALTH, INC. via NOMI HEALTH, INC.
2026 · second_quarter · Q2
Patients Deserve Price Tags Act (S. 2355/H.R. 5582); Health Data Access, Transparency, and Affordability Act of 2026 (H.R. 9228); issues related to federal employee healthcare; legislation related to tax-advantaged health savings vehicles; healthcare financial services policies; healthcare waste, fraud, and abuse; legislative concepts related to direct contracting in employer-sponsored healthcare; anti-competitive practices and anti-tiering/anti-steering legislation.
ERISA healthcare issues; employer data ownership and transparency legislation; regulations on service provider fee disclosure.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL), Office of Management & Budget (OMB), Office of Personnel Management (OPM), SENATE
NOMI HEALTH, INC. via NOMI HEALTH, INC.
2026 · first_quarter · Q1
ERISA healthcare issues; employer data ownership and transparency legislation; regulations on service provider fee disclosure.
Patients Deserve Price Tags Act (S. 2355/H.R. 5582); issues related to federal employee healthcare; legislation related to tax-advantaged health savings vehicles; healthcare financial services policies; healthcare waste, fraud, and abuse; legislative concepts related to direct contracting in employer-sponsored healthcare; anti-competitive practices and anti-tiering/anti-steering legislation.
Filing targets: HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL), Office of Personnel Management (OPM), SENATE
NOMI HEALTH, INC. via NOMI HEALTH, INC.
2025 · fourth_quarter · Q4
Patients Deserve Price Tags Act (S. 2355/H.R. 5582), legislation related to tax-advantaged health savings vehicles; healthcare financial services policies; healthcare waste, fraud, and abuse; legislative concepts related to direct contracting in employer-sponsored healthcare; anti-competitive practices and anti-tiering/anti-steering legislation.
ERISA healthcare issues; employer data ownership and transparency legislation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NOMI HEALTH, INC. via NOMI HEALTH, INC.
2025 · third_quarter · Q3
Patients Deserve Price Tags Act (S. 2355), legislation related to tax-advantaged health savings vehicles; healthcare financial services policies; healthcare waste, fraud, and abuse; legislative concepts related to direct contracting in employer-sponsored healthcare; anti-competitive practices and anti-tiering/anti-steering legislation.
ERISA healthcare issues; employer data ownership and transparency legislation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NOMI HEALTH, INC. via NOMI HEALTH, INC.
2025 · second_quarter · Q2
Pharmacy benefit manager policies and legislation; legislation related to tax-advantaged health savings vehicles; healthcare financial services policies; healthcare cybersecurity policies; healthcare waste, fraud, and abuse; healthcare/ERISA transparency legislation; anti-competitive practices and anti-tiering/anti-steering legislation.
ERISA healthcare issues; employer data ownership and transparency legislation.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL), SENATE
NOMI HEALTH, INC. via NOMI HEALTH, INC.
2025 · first_quarter · Q1
Pharmacy benefit manager policies and legislation; legislation related to tax-advantaged health savings vehicles; healthcare financial services policies; healthcare cybersecurity policies; healthcare/ERISA transparency legislation; anti-competitive practices and anti-tiering/anti-steering legislation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NOMI HEALTH, INC. via NOMI HEALTH, INC.
2024 · fourth_quarter · Q4
pharmacy benefit manager policies and legislation; medication-assisted treatment expansion; HOPE Act (H.R. 9394); telehealth controlled substances legislation; healthcare financial services policies; healthcare cybersecurity policies; S. 5218 (related to healthcare cybersecurity); Healthcare Cybersecurity Act of 2024 (S. 4697/H.R. 9412).
Fiscal Year (FY 2025) Labor-HHS-Education Appropriations; COVID funding and related issues
Telehealth policies related to veterans behavioral health.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NOMI HEALTH, INC. via NOMI HEALTH, INC.
2024 · third_quarter · Q3
Telehealth policies related to veterans behavioral health.
GOLD CARD Act of 2023 (H.R. 4968); pharmacy benefit manager policies and legislation; medication-assisted treatment expansion; telehealth controlled substances legislation; healthcare financial services policies; healthcare cybersecurity policies; S. 5218 (related to healthcare cybersecurity); Healthcare Cybersecurity Act of 2024 (S. 4697/H.R. 9412).
Fiscal Year (FY 2025) Labor-HHS-Education Appropriations; COVID funding and related issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
NOMI HEALTH, INC. via NOMI HEALTH, INC.
2024 · second_quarter · Q2
Fiscal Year (FY 2025) Labor-HHS-Education Appropriations; COVID funding and related issues
Reentry Act of 2023 (H.R. 2400/S. 1165); Support for Patients and Communities Reauthorization Act (H.R. 4531/S. 3393); Due Process Continuity of Care Act (H.R. 3074/S. 971); GOLD CARD Act of 2023 (H.R. 4968); Pharmacy benefit manager policies and legislation; Medication-assisted treatment expansion; healthcare financial services policies; healthcare cybersecurity policies
Filing targets: Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), HOUSE OF REPRESENTATIVES, SENATE
NOMI HEALTH, INC. via NOMI HEALTH, INC.
2024 · first_quarter · Q1
Reentry Act of 2023 (H.R. 2400/S. 1165); Support for Patients and Communities Reauthorization Act (H.R. 4531/S. 3393); Due Process Continuity of Care Act (H.R. 3074/S. 971); GOLD CARD Act of 2023 (H.R. 4968); Pharmacy benefit manager policies and legislation; Medication-assisted treatment expansion; healthcare financial services policies; healthcare cybersecurity policies
Fiscal Year (FY 2025) Labor-HHS-Education Appropriations; COVID funding and related issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NOMI HEALTH, INC. via NOMI HEALTH, INC.
2023 · fourth_quarter · Q4
Reentry Act of 2023 (H.R. 2400/S. 1165); Support for Patients and Communities Reauthorization Act (H.R. 4531/S. 3393); Due Process Continuity of Care Act (H.R. 3074/S. 971); GOLD CARD Act of 2023 (H.R. 4968); Pharmacy benefit manager policies and legislation; Medication-assisted treatment expansion
Fiscal Year (FY 2024) Labor-HHS-Education Appropriations (H.R. 5894/S. 2624); COVID funding and related issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NOMI HEALTH, INC. via NOMI HEALTH, INC.
2023 · fourth_quarter · RR
Reentry Act of 2023 (H.R. 2400/S. 1165) Support for Patients and Communities Reauthorization Act (H.R. 4531/S. 3393) Due Process Continuity of Care Act (H.R. 3074/S. 971) Fiscal Year (FY 2024) Labor-HHS-Education Appropriations (H.R. 5894/S. 2624) COVID funding and related issues Pharmacy benefit manager policies and legislation Medication-assisted treatment expansion
Reentry Act of 2023 (H.R. 2400/S. 1165) Support for Patients and Communities Reauthorization Act (H.R. 4531/S. 3393) Due Process Continuity of Care Act (H.R. 3074/S. 971) Fiscal Year (FY 2024) Labor-HHS-Education Appropriations (H.R. 5894/S. 2624) COVID funding and related issues Pharmacy benefit manager policies and legislation Medication-assisted treatment expansion